[HTML][HTML] Poorer prognosis of idiopathic pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis in advanced stage

M Shioya, M Otsuka, G Yamada, Y Umeda… - Canadian respiratory …, 2018 - hindawi.com
Objective. Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare disease characterized
by predominant upper lobe pulmonary fibrosis of unknown etiology. However, the …

Validation of the Japanese disease severity classification and the GAP model in Japanese patients with idiopathic pulmonary fibrosis

S Kondoh, H Chiba, H Nishikiori, Y Umeda… - Respiratory …, 2016 - Elsevier
Background The clinical course of idiopathic pulmonary fibrosis (IPF) shows great inter-individual
differences. It is important to standardize the severity classification to accurately …

[HTML][HTML] Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis

…, M Otsuka, H Chiba, K Ikeda, Y Mori, Y Umeda… - BMC pulmonary …, 2020 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is a progressive and fibrosing lung disease
with poor prognosis. Pirfenidone and nintedanib are anti-fibrotic drugs used for patients with …

Volatile organic compounds in exhaled breath of idiopathic pulmonary fibrosis for discrimination from healthy subjects

…, G Yamada, M Otsuka, H Nishikiori, K Ikeda, Y Umeda… - Lung, 2017 - Springer
Purpose Human breath analysis is proposed with increasing frequency as a useful tool in
clinical application. We performed this study to find the characteristic volatile organic …

Feasibility of rapid on‐site cytological evaluation of lung cancer by a trained pulmonologist during bronchoscopy examination

Y Umeda, M Otsuka, H Nishikiori, K Ikeda… - …, 2019 - Wiley Online Library
Objective Rapid on‐site cytological evaluation ( ROSE ) in bronchoscopy is a useful ancillary
technique. ROSE is usually performed by a cytopathologist or cytotechnologist. However, …

Autoimmune pulmonary alveolar proteinosis diagnosed after exposure to a fire extinguisher containing silica powder

…, Y Takahashi, T Taya, Y Mori, Y Umeda… - Internal …, 2019 - jstage.jst.go.jp
We herein report a case of autoimmune pulmonary alveolar proteinosis (PAP) diagnosed
after one-time exposure to silica powder. Owing to the misuse of a silica-containing fire …

[HTML][HTML] Occult ovarian clear-cell carcinoma diagnosed as primary adenocarcinoma of the lung: a case report of a diagnostic pitfall for clinicians and pathologists

…, M Tsujiwaki, Y Sudo, Y Asai, Y Umeda… - … medicine case reports, 2018 - Elsevier
We present a case of ovarian clear-cell carcinoma that was initially diagnosed as adenocarcinoma
of lung origin. This is an instructive diagnostic pitfall for clinicians and pathologists …

Distinct profiles of Th1 and Th2 cytokines in patients with IPF, CTD-ILD, and IPAF

…, T Hasegawa, T Yoshikawa, T Kobayashi, Y Umeda… - 2019 - Eur Respiratory Soc
Background: Interstitial lung diseases (ILD) are characterized by inflammation and/or fibrosis
of the lungs. Patients with idiopathic pulmonary fibrosis (IPF) are unlikely to respond to …

Clinical Characteristics Of Combined Pulmonary Fibrosis And Emphysema

Y Umeda, M Otsuka, Y Kitamura… - C46. IDIOPATHIC …, 2012 - atsjournals.org
Background In recent years, combined pulmonary fibrosis and emphysema (CPFE) has
been defined as a new disease entity and its pathogenesis and clinical features have been …

Change in serum surfactant protein (SP)-A, SP-D and KL-6 predict the therapeutic effect of antifibrotic drugs in IPF

T Yoshikawa, M Otsuka, K Ikeda, Y Mori, Y Umeda… - 2019 - Eur Respiratory Soc
Background: Serum surfactant protein (SP)-A, SP-D, and KL-6 are prognostic biomarkers of
patients with idiopathic pulmonary fibrosis (IPF), however, the relationship with the …